TC BioPharm signs LoI to acquire ophthalmic pharma company
TC BioPharm has signed a non-binding LoI to acquire a pharma company focused on commercialising intraocular pressure minimising therapies.
TC BioPharm has signed a non-binding LoI to acquire a pharma company focused on commercialising intraocular pressure minimising therapies.
What's Your Reaction?
